NDC 73352-830-01 - Tridacaine II
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73352-830
- Requested NDC
- 73352-830-01
- Package NDCs from labels
- 73352-830-01, 73352-830-15
- Manufacturer
- Trifluent Pharma LLC
- Effective date
- 2026-06-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tridacaine II - Trifluent Pharma LLC | Trifluent Pharma LLC | 2026-06-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73352-830-01 | Tridacaine II | 1 g in 1 PACKET | PATCH | 1 | 5 | |
| 73352-830-15 | Tridacaine II | 15 in 1 POUCH | PATCH | 15 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 73352-830-01 | EA - Each | 73352-830 | e1308b3c-8a39-4e8e-b178-c76ed0894aa1 | 1 | 2024-06-10 |
| 73352-830-15 | EA - Each | 73352-830 | 4efa7e9a-2d01-4f02-8936-235f99447642 | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NICOVITO HEMORRHOID MASTER | LIDOCAINE 4% PHENYLEPHRINE HCL 0.25% HEMORRHOID MASTER | Jiangxi Yudexi Pharmaceutical Co., LTD | 4a5e24fa-959e-79b4-e063-6294a90a8f68 | 2026-02-09 | Warnings | 98PI200987 |
| Welmate Lidocaine Pain Relieving Patch | LIDOCAINE | YYBA CORP | 4303fd30-0d35-3671-e063-6394a90a2aee | 2026-02-09 | Warnings | 98PI200987 |
| Pain Relief Lidocaine | LIDOCAINE | Kroger Company | 4098756e-3d9f-317a-e063-6394a90af04c | 2026-02-09 | Warnings | 98PI200987 |
| Droptics Performance Eye Drops | NAPHAZOLINE HYDROCHLORIDE, PROPYLENE GLYCOL | Droptics LLC | 20fd6822-a7fd-4593-92bb-0a07260893e2 | 2026-02-09 | Warnings | 6DC9Q167V3 |
| Hemorrhoid Master | LIDOCAINE, PHENYLEPHRINE | Ebanel Laboratories, Inc | 41292d65-dabe-4bc3-872f-34a3912aa342 | 2026-02-09 | Warnings | 98PI200987 |
| Numb Master | LIDOCAINE | Clinical Resolution Laboratory, Inc. | 0921c824-a8a9-4707-a480-c750192983f5 | 2026-02-09 | Warnings | 98PI200987 |
| ASSIELF NUMBING Topical Anorectal | LIDOCAINE | Shenzhen Yuanbang International Logistics Co., Ltd | 4a5cb477-57ef-2a1d-e063-6394a90ac9ed | 2026-02-08 | Warnings | 98PI200987 |
| Lidocaine Pain Relieve Gel-Patch | PAIN RELIEVE GEL-PATCH | Henan Kangdi Medical Devices Co., Ltd | 1e31b950-e990-e255-e063-6394a90a7d23 | 2026-02-07 | Warnings | 98PI200987 |
| Lidocaine Pain Relief Gel-Patch | LIDOCAINE | Shenzhen Wankelai E-commerce Co., Ltd. | 4a22562b-601e-97d7-e063-6394a90a5bca | 2026-02-06 | Warnings | 98PI200987 |
| Pain Relief Gel-Patch | LIDOCAINE 4% | Sportpharm LLC | 1dd022b9-88ae-4737-88cc-fdb0ce0a83a3 | 2026-02-06 | Warnings | 98PI200987 |
| Camphor plus Lidocaine Pain Relief | CAMPHOR, LIDOCAINE | Veridian Healthcare | 4a2b73a8-c10c-85f9-e063-6294a90ac52c | 2026-02-06 | Warnings | 98PI200987 |
| Numbing Cream | LIDOCAINE | Sainite Trading Shenzhen Co., Ltd. | 49fcbe81-34b6-5906-e063-6294a90aa65b | 2026-02-04 | Warnings | 98PI200987 |
| Lidocaine | LIDOCAINE | PHOENIX RX LLC | 40949067-a5a8-db8c-e063-6294a90af0fb | 2026-02-04 | Warnings, Adverse reactions | 98PI200987 |
| MINIDROPS | LUBRICANT EYE DROPS | Optics Laboratory, Inc | c13c5f91-50df-471c-a7c9-1747a2ac1250 | 2026-02-03 | Warnings | 532B59J990 |
| Numbsure LIDOCAINE | LIDOCAINE 4% | Hambli Limited | 43a65a12-ef2a-4608-e063-6394a90a82ea | 2026-01-31 | Warnings | 98PI200987 |
| Collajoint Lidocaine Pain Relief Gel Patch | LIDOCAINE PAIN RELIEF GEL PATCH | Henan Enokon Medical Instrument Co., Ltd. | 44e27e7f-992f-d194-e063-6294a90a94e4 | 2026-01-31 | Warnings | 98PI200987 |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Alveora HEMORRHOID MASTER | LIDOCAINE 4% PHENYLEPHRINE HCL 0.25% HEMORRHOID MASTER | Jiangxi Yudexi Pharmaceutical Co., LTD | 4996f96a-898e-de01-e063-6394a90a3907 | 2026-01-30 | Warnings | 98PI200987 |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.